Cenova is healthcare dedicated funds invests in healthcare services, diagnostics, medical devices, and pharmaceuticals.
Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. Cenova Capital is healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sector in China. Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath. Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jun 20, 2022
Yuanyin Bio
|
Series A | ¥280M | Biopharma | — |
Nov 29, 2021
Yuanyin Bio
|
Seed | ¥100M | Biopharma | — |
Mar 5, 2021
Forerunner Medical
|
Series B | ¥100M | Biotechnology | — |